Risdiplam, sold under the brand name Evrysdi, is a medication used to treat spinal muscular atrophy and is the first oral medication approved to treat this disease by the US Food and Drug Administration. From Wikipedia
Published RAINBOWFISH findings underpin broader authorization for infants under two months, prompting exploration of prenatal intervention
